Logo image
Adipocytokines, Inflammation, and Breast Cancer Risk in Postmenopausal Women: A Prospective Study
Journal article   Open access   Peer reviewed

Adipocytokines, Inflammation, and Breast Cancer Risk in Postmenopausal Women: A Prospective Study

Amy L. Gross, Craig J. Newschaffer, Judith Hoffman-Bolton, Nader Rifai and Kala Visvanathan
Cancer epidemiology, biomarkers & prevention, v 22(7), pp 1319-1324
01 Jul 2013
PMID: 23651666
url
https://doi.org/10.1158/1055-9965.epi-12-1444View
Accepted (AM)Open Access (License Unspecified) Open
url
https://doi.org/10.1158/1055-9965.EPI-12-1444View
Published, Version of Record (VoR) Open

Abstract

Life Sciences & Biomedicine Oncology Public, Environmental & Occupational Health Science & Technology
Obesity is a known risk factor for postmenopausal breast cancer; it has been postulated that adipocytokines may mediate this association. We explored the relationship between three markers altered by obesity: leptin, adiponectin, and soluble tumor necrosis factor receptor 2 (sTNF-R2), an inflammatory marker, with breast cancer risk in postmenopausal women. A nested case-control study of postmenopausal women was conducted within CLUE II, a prospective population-based cohort. Baseline plasma levels of leptin, adiponectin, and sTNF-R2 were assayed in 272 female breast cancer cases and 272 controls matched on age, date, and hour of blood draw. Conditional logistic regression was used to estimate matched odds ratios (OR) and 95% confidence intervals (CI). sTNF-R2 and leptin were independently positively associated with breast cancer risk in adjusted models. The OR for breast cancer comparing the highest to lowest tertile was 2.44 (95% CI: 1.30-4.58) for sTNF-R2 and 1.98 (95% CI: 1.20-3.29) for leptin. While higher levels of adiponectin were protective (OR for the lowest tertile = 1.63; 95% CI: 1.02-2.60), there was no dose response. A 20% reduction in the breast cancer risk associated with overweight/obesity was observed when sTNF-R2 alone was included in multivariable models. Including both sTNF-R2 and adiponectin in the models resulted in a 29% reduction in the OR. Adipocytokines and sTNF-R2 are important factors in the etiology of postmenopausal breast cancer due to adiposity. This study informs our understanding of the relationship between obesity, inflammation, and postmenopausal breast cancer and identifies potential biomarkers. 24. (C) 2013 AACR.

Metrics

6 Record Views
63 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Oncology
Public, Environmental & Occupational Health
Logo image